Repligen reported $148.08M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agilent A:US USD 1.38B 71M
Align Technology ALGN:US USD 746.69M 34.66M
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Bruker BRKR:US USD 507.6M 6.9M
Catalent CTLT:US USD 962M 105M
Charles River Laboratories CRL:US USD 838.18M 52.46M
Danaher DHR:US USD 5.65B 102M
Dentsply International XRAY:US USD 2.16B 1.26B
Exact Sciences EXAS:US USD 661.13M 20.09M
Fluidigm FLDM:US USD 54.67M 2.67M
General Electric GE:US USD 19.42B 1.63B
Henry Schein HSIC:US USD 2.86B 46M
Illumina ILMN:US USD 4.77B 3.03B
IQVIA Holdings Inc IQV:US USD 3.09B 2M
Mettler Toledo International MTD:US USD 709.96M 11.73M
Myriad Genetics MYGN:US USD 201.4M 4.3M
Nanostring Technologies NSTG:US USD 64.48M 4.83M
Orasure Technologies OSUR:US USD 115.59M 14.07M
Patterson Companies PDCO:US USD 1.57B 77.69M
Peregrine Pharmaceuticals PPHM:US USD 33.96M 3.8M
Pfizer PFE:US USD 13.23B 2.41B
Repligen RGEN:US USD 148.08M 3.61M
Thermo Fisher Scientific TMO:US USD 8.97B 2M
Waters WAT:US USD 516.54M 1.86M
West Pharmaceutical Services WST:US USD 550.3M 7M